Getting to know him and especially to work with Todd on ideas and experiments he thinks up, is a great honor. This sentiment is shared by all at Mercaptor Discoveries.
Dr. Zankel co-founded and seed-funded Mercaptor Discoveries Inc., a direct descendant of the Discovery group at Raptor Pharmaceuticals, Inc. Raptor ceased operations in 2016. Mercaptor is focused on proprietary molecules conceived to treat neuronal injury and neurodegeneration. Todd also co-founded Raptor Pharmaceuticals and served as its Chief Scientific Officer from 2006 to 2016. From 1997 to 2005,